Navigation Links
Biolistic Transfection of Organotypic Brain Slices

Microprojectile Preparation
The protocol for coating 1.6 m gold particles and loading macrocarriers is the same as described above for transfecting cell lines, except that for slice transfection, we never use more than one standard recipe of gold for 6 shots. Standard recipe = 50 l of a 60 mg gold/ 1,000 l distilled H2O stock solution.

Transfecting Brain Slices
We have made several modifications to the procedure recommended by Bio-Rad which are crucial to obtaining healthy, transfected neurons in brain slices, although these changes are not important for transfection of cell lines. The primary issue in determining slice health is balancing a sufficiently high helium pressure for gold particle penetration of the slice with the need to minimize the tissue-damaging shock wave resulting from high helium pressures. For slices, we have found 1,100 psi of helium to be optimal. Three modifications have been applied to decrease the damaging effects of the rupture shock wave. First, a 3" square piece of nylon mesh (95 m mesh opening, 39% open area; Small Parts, Miami Lakes, FL) is cut and attached to the base of the launch assembly, serving to baffle much of the helium shock wave. Second, the Millicell insert containing the slices is placed onto an inch square slab of agarose (1.85%, 0.25" thick) on a cooled aluminum block (approx. 2"x 2"x 0.5") on the target tissue shelf 9 cm away from the launch assembly. The agar acts to absorb the residual shock wave while cooling ameliorates secondary neuronal trauma. Finally, the chamber is flushed with helium through a custom-fitted access valve prior to pulling the final vaccuum so that the residual gas is helium and not
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Using the VersaFluor Fluorometer to Quantitate GUS Expression in Plant Tissues Bombarded With the Biolistic PDS-1000/He System
2. Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A
3. Comparison of Performance Characteristics of Different Biolistic Devices
4. Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System
5. Sub-Micron Gold Particles Are Superior to Larger Particles for Efficient Biolistic Transformation of Organelles and Some Cells
6. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
7. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
10. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
11. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biolistic Transfection Organotypic Brain Slices

(Date:7/2/2008)... 2 /- Aureus Pharma, a leading provid... discovery in the life science,industry, announced...will,be held in Paris on October 23rd and 24th., ...ul inaugural event,which was attended by many of A...oth Europe and North America. The symposium includ...
(Date:7/2/2008)...Advance Commercialization of Expanded Portfolio of... VANCOUVER, British Columbia, July 2 /PRNewswire/...tures Corp. (TSXV: MEV), a company developing and,...oday announced its name,change and the expansion o...the acquisition of two vascular product developmen...
(Date:7/2/2008)...oints to potential of pre-treatment R2 levels as a... activity -, TORONTO, July 2 /PRNewswire-FirstCal... ("Lorus" or the "Corporation"), a biopharmaceutic...pment of pharmaceutical products and,technologies ...ication by,an Ohio State University (OSU) clinical...
(Date:7/1/2008)... N.J., July 2 /- Schering-P...e successful closing of its,previously announced t...th,products from selected franchises. These divest... part of its October 2007 clearance of the,acquisi...ac acquired products from the endocrine, mastitis ...
Breaking Biology Technology:Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
... Isolate and Enrich for Bacterial mRNA ,...icroarray Analysis , The rapid increase i...omes sequenced over the past , ...ome , expression analysis using... years, this tool has been used to explore...
... , No more siRNA design a... complete in 1 day , ...paration, RNase , III digestion and siR... Silencing Experiments The , ...) to induce targeted gene , sil...
...t Full-length cDNA , Ambion scientists ...nscriptase , to improve production of ful...se, , <A , href="http:...ipt , (patent pending), produces signifi...A than wild type RTs, and rivals even the newest e...
...bion now offers a complete Gene Expression Profili...s. From basic data analysis to our Full Service of...all. The Full Service offering includes , c...y and informatics scientists , and comprehe...iding innovative, , high quality products a...
Other Biology Technology:Bacterial Whole Genome Array Analysis 2Bacterial Whole Genome Array Analysis 3Bacterial Whole Genome Array Analysis 4Bacterial Whole Genome Array Analysis 5Bacterial Whole Genome Array Analysis 6Bacterial Whole Genome Array Analysis 7Avoid siRNA Design Altogether! 2Avoid siRNA Design Altogether! 3ArrayScript RT: Maximize Yields of Full-length cDNA 2ArrayScript RT: Maximize Yields of Full-length cDNA 3Ambion Offers Gene Expression Profiling Service 2Ambion Offers Gene Expression Profiling Service 3
(Date:7/2/2008)...want to produce a lot of a substance -- such as a ...s, molecules that speed chemical reactions. Many j...ing one in just the right shape to connect with ce...s, such as enzymes in the human body that help us ...ting to suit the task at hand. , Chemists have m...
(Date:7/2/2008)...erman . , Metabolomics aims to determine the tot.... The exponents of bioinformatics analyzed data co...omics study in healthy and diabetic mice. In each ...he diabetes drug RoziglitazoneTM. Then, more than ...a blood plasma sample of a total of forty mice, re...
(Date:7/2/2008)...Spanish . , Most of the functions performed by ...eins, which recognise their binding partner by aff...here are many kinds of interactions; however, the ...structural biology are those which are transient. ...gh a large section of the protein surface- the glo...
(Date:7/2/2008)... of its kind, using sophisticated methods to measu...al weight loss program, Weight Watchers, was compa...ethod wins in the game of good health. A Universit...periences of participants to determine which progr...ain health benefits. The answer is that both have ...
Breaking Biology News(10 mins):Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Weight Watchers vs. fitness centers 2Flexible Medical Systems Raises 241 2M Seed Investment for Initial Human Trials 350 1Flexible Medical Systems Raises 241 2M Seed Investment for Initial Human Trials 350 2Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 1Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 2Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 3Teenage Drinking Can Spell Lasting Trouble 1742 1Teenage Drinking Can Spell Lasting Trouble 1742 2Teenage Drinking Can Spell Lasting Trouble 1742 3Pathway to cell death redefined in landmark study 1739 1Pathway to cell death redefined in landmark study 1739 2Pathway to cell death redefined in landmark study 1739 3Pathway to cell death redefined in landmark study 1739 4
...fied a cell population that is a primary target of...poral dementia, which is as common as Alzheimer,s ...e 65. , Because the cells arose only recently in ...eat apes and humans-- and are particularly abundan...that evolution has rendered the human brain vulner...
... an antibiotic in a non-native host has provided a... at Urbana-Champaign with the potential for develo...e rapid rise of antibiotic resistance poses a seri...ents effective against resistant pathogens. Fosfom...and Drug Administration for the treatment of vario...
...ffer hearing loss due to the toxic effects of chem...g back through pharmacological and gene therapy, t...hildren,s Research Hospital. Mice with a variety o...f the ear will also help scientists understand age...g loss caused by long-term exposure to loud noise,...
...from global warming? Perhaps, but the tradeoffs in...uclear waste generated each year and a greatly inc...version of nuclear material into terrorists, hands... Rodney Ewing, who has analyzed just how much nucl...ly reduce greenhouse gas emissions worldwide, and ...
Other Biology News:Study offers window into human behavior, brain disease 2Study offers window into human behavior, brain disease 3Study offers window into human behavior, brain disease 4Cloning techniques produce FDA-approved antibiotic 2St. Jude finds clues to hearing loss from chemotherapy 2Plutonium or greenhouse gases? Weighing the energy options 2
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP.
Edited by D. Rickwood, T.C. Ford and J.T. Steensgaard (1994) Compiles core data required by researchers carrying out any centrifugal separation, whether working with cells, organelles or macromolec
MOUSE ANTI PROTEIN KINASE C BETA 2 Immunogen: Protein kinase C beta 2
The Captivate magnetic separator for six microtubes can be used in conjunction with the Captivate ferrofluid conjugates (C-21473, C-21474, C-21476) or other magnetic particles and can accommodate s
Biology Products: